• Neurocrine Biosciences average gross margin for 2023 was 98.01%, a 0.56% increase from 2022.
• Neurocrine Biosciences average gross margin for 2022 was 98.56%, a 0.28% decline from 2021.
• Neurocrine Biosciences average gross margin for 2021 was 98.84%, a 0.28% decline from 2020.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.